KENILWORTH, N.J. -- Schering Laboratories announced today that the Web Marketing Association, Inc., (WMA), an organization devoted to recognizing excellence in corporate Web sites worldwide, has awarded the Outstanding Web Site of 2002 to Clarinex.com, the official online resource for CLARINEX(R) (desloratadine), the only nonsedating antihistamine approved for the treatment of indoor and outdoor allergies, as well as chronic idiopathic urticaria (CIU), or hives of unknown cause.
Always ask a doctor before giving a cold or allergy medicine to a child. Death can occur from the misuse of cough and cold medicines in very young children.
Schering-Plough Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved CLARINEX-D(R) 24 HOUR (desloratadine 5mg and pseudoephedrine sulfate USP 240 mg) Extended Release Tablets for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis (outdoor allergies), including nasal congestion, in patients 12 years of age and older.
|
